Pediatrix Medical (MD) Net Margin (2009 - 2026)

Pediatrix Medical has disclosed Net Margin across 17 years of filings, most recently posting 6.21% for Q1 2026.

• In Q1 2026, Net Margin rose 169.0% year-over-year to 6.21%; the TTM figure through Mar 2026 stood at 9.52% (up 1379.0% YoY), while the FY2025 annual figure was 9.14%, changed N/A from the prior year.
• Net Margin fell to 6.21% in Q1 2026, from 8.77% in the prior quarter.
• Over the last five years, Net Margin for MD reached as high as 14.55% in Q3 2025 and fell as low as 30.34% in Q2 2024.
• The 4-year median for Net Margin is 3.8% (2024), against an average of 1.77%.
• Annual changes were most pronounced in 2022 — Net Margin tumbled 280 bps — and 2025, when it surged 3872 bps.
• A 4-year view of Net Margin shows it stood at 1.1% in 2022, then jumped by 412 bps to 5.64% in 2024, then surged by 56 bps to 8.77% in 2025, then dropped by 29 bps to 6.21% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 6.21%, 8.77%, and 14.55% for Q1 2026, Q4 2025, and Q3 2025 respectively.